UnitedHealth Q2 earnings shock: 2025 forecast slashed amid soaring medical costs
Uitedhealth made the second quarter of the disappointing, and the rising medical costs became conservative with 2025 estimation because the insurance companies continued to swamp.
Health giant, on Tuesday when the prices of the prices will continue to pressure the performance of the expects to continue to press the performance, he said. However, CEO Stephen Hemsley told analysts that the company returned to “solid but moderate gain growth in 2026.
Unitedhealth is waiting for at least $ 16 per share in 2025 after withdrawing his previous estimate in May. It began with expectations of 2025 up to $ 30 per share.
According to the data company Factset, analysts estimate $ 20.64 per share.
Core Businesses and Operations
Unitedhealth Group Inc. is running one of the country’s largest health insurance and pharmacy benefit management businesses. Eden Prairie, Minnesota, the company also runs a growing optum business that provides maintenance and technology support.
Leadership shake in the middle of cost fluctuation
In May, the company withdrew its estimation 2025 due to higher medical costs than expected and suddenly left the CEO Andrew Witty company. President Stephen Hemsley, who has been the CEO of Unitedhealth for more than ten years until 2017, was passed.
This came after taking the company’s rare step in April. This has fell $ 130 in Unitedhealth’s worst one -day performance for more than 25 years.
In June, Hemsley promised to create a “cautious” 2025 gain look in detail in the second quarter of Unitedhealth in June. He said on Tuesday that the company made operational mistakes and errors in determining the pricing this year, but these problems provide “needed”.
Company leaders, for example, said that they expect 5% growth to grow for Medicare Advantage and that they are actually progressing more than 7%.
A few other insurance companies said this month was also affected by the medical costs that grow faster than expected. Companies saw an increase in expensive emergency visits, and United -Eller leaders said on Tuesday that doctors were invoiced for more tests and services than they expected during these visits.
Prescription drug costs contribute to printing
Insurers are also interested in prescription drug costs, as well as expensive treatments for cancer and obesity, as well as increased prescription drugs from gene therapy.
In the second quarter, Unitedhealth was reported to be $ 111.6 billion per share of $ 4.08 -per -$ 4.08 per share. According to Factset, analysts expected to generate $ 4.48 per share.
Although the income increased by 13%, the company’s profit fell by 19% to $ 3.41 billion. Medical costs, the largest operating expense of the company, increased by 20% in the quarter to $ 78.6 billion.
Unitedhealth shares fell by 4% on Tuesday.
This price reached $ 630 last November. However, the stock has mostly gained value since December, when it was deadly hit by the company’s annual investor meeting in Midtown Manhattan, the CEO of Unitedhealthcare.
As of Monday, the share fell by 44% this year. The Dow Jones industrial average, a member of Unitedhealth, climbed by 5%.
